Syngene Intl.

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE398R01022
  • NSEID: SYNGENE
  • BSEID: 539268
INR
451.85
14.25 (3.26%)
BSENSE

Nov 20

BSE+NSE Vol: 28.02 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 197397,
    "name": "Syngene Intl.",
    "stock_name": "Syngene Intl.",
    "full_name": "Syngene International Ltd",
    "name_url": "stocks-analysis/syngene-intl",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "451.85",
    "chg": 14.25,
    "chgp": "3.26%",
    "dir": 1,
    "prev_price": "437.60",
    "mcapval": "17,820.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539268,
    "symbol": "SYNGENE",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE398R01022",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "28.02 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/syngene-intl-197397-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syngene International Ltd Downgraded to Strong Sell Amid Weak Financials and Valuation Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/syngene-international-ltd-downgraded-to-strong-sell-amid-weak-financials-and-valuation-concerns-4264738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SyngeneInternat_mojoScore_4264738.png",
        "date": "2026-11-17 08:12:45",
        "description": "Syngene International Ltd, a key player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMojo as of 16 Nov 2026. This revision reflects deteriorating financial performance, stretched valuation metrics, weakening technical indicators, and a declining quality score, signalling heightened risks for investors amid ongoing underperformance."
      },
      {
        "title": "Syngene International Gains 6.59%: Technical Shift Amid Persistent Financial Challenges",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syngene-international-gains-659-technical-shift-amid-persistent-financial-challenges-4262675",
        "imagepath": "",
        "date": "2026-11-15 14:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Nov:</strong> Rating upgraded to Sell on technical improvements</p>\n                    <p><strong>11 Nov:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>13 Nov:</strong> Week closes at Rs.444.70 (+6.59%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.417.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.444.70</div><div class=\"stat-change positive\">+6.59%</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-l..."
      },
      {
        "title": "Syngene International Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/syngene-international-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-financials-4257078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SyngeneInternat_mojoScore_4257078.png",
        "date": "2026-11-10 08:08:47",
        "description": "Syngene International Ltd, a key player in the healthcare services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 9 November 2026. This change reflects a nuanced shift in the company’s technical outlook amid ongoing financial headwinds and valuation concerns. While the technical indicators have improved to a sideways trend, fundamental challenges persist, prompting a cautious stance from investors."
      },
      {
        "title": "Syngene International Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/syngene-international-ltd-is-rated-strong-sell-4256591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SyngeneInternat_mojoScore_4256591.png",
        "date": "2026-11-09 10:10:56",
        "description": "Syngene International Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 30 July 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 November 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Syngene International Ltd Gains 9.73%: 4 Key Factors Driving the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syngene-international-ltd-gains-973-4-key-factors-driving-the-rally-4246550",
        "imagepath": "",
        "date": "2026-11-01 14:00:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens at Rs.359.75, declines 1.95% amid broad market gains</p>\n                    <p><strong>27 Oct:</strong> Modest recovery with 1.74% gain to Rs.366.00</p>\n                    <p><strong>28 Oct:</strong> Exceptional volume surge and intraday high of Rs.412.70, closing at Rs.411.70 (+12.49%)</p>\n                    <p><strong>29 Oct:</strong> Profit booking leads to 3.25% decline to Rs.398.30</p>\n                    <p><strong>30 Oct:</strong> Slight rebound of 1.08% to close the week at Rs.402.60</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class..."
      },
      {
        "title": "Syngene International Ltd Surges on High-Value Trading Amid Institutional Interest",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syngene-international-ltd-surges-on-high-value-trading-amid-institutional-interest-4242459",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SyngeneInternat_most_active_equities_by_value_4242459.png",
        "date": "2026-10-28 15:00:10",
        "description": "Syngene International Ltd, a prominent player in the healthcare services sector, witnessed a remarkable surge in trading value on 28 Oct 2026, driven by robust volume and significant price appreciation. Despite its strong intraday performance, the stock remains under scrutiny due to its recent downgrade to a Strong Sell by MarketsMOJO, reflecting a complex interplay of market enthusiasm and cautious institutional sentiment."
      },
      {
        "title": "Syngene International Ltd Sees Exceptional Volume Surge Amid Strong Sell Rating",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syngene-international-ltd-sees-exceptional-volume-surge-amid-strong-sell-rating-4242458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SyngeneInternat_most_active_equities_by_volume_4242458.png",
        "date": "2026-10-28 15:00:08",
        "description": "Syngene International Ltd, a prominent player in the healthcare services sector, witnessed an extraordinary surge in trading volume on 28 Oct 2026, accompanied by a robust price rally. The stock outperformed its sector and broader market indices, signalling renewed investor interest despite a recent downgrade in its mojo rating."
      },
      {
        "title": "Syngene International Ltd Surges 7.54% to Day's High of Rs 395.95 — Outperforms Sector by 6.74 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syngene-international-ltd-hits-intraday-high-with-754-surge-on-28-oct-2026-4242321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SyngeneInternat_priceRelatedfactors_4242321.png",
        "date": "2026-10-28 12:21:35",
        "description": "The Sensex declined 0.69% on 28 Oct 2026, while Syngene International Ltd surged 7.54%, outperforming its Healthcare Services sector by 6.74 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop."
      },
      {
        "title": "Syngene International Ltd Shows Mixed Technical Signals Amid Prolonged Downtrend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syngene-international-ltd-shows-mixed-technical-signals-amid-prolonged-downtrend-4241381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SyngeneInternat_technicaldot_4241381.png",
        "date": "2026-10-28 08:01:00",
        "description": "Syngene International Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent 1.74% rise in its share price to ₹366.00, the stock remains under pressure with a strong sell rating and a significant year-to-date decline of 43.8%, underscoring the challenges facing investors amid mixed technical indicators."
      }
    ],
    "total": 113,
    "sid": "197397",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/syngene-international-197397"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "16-Nov-2026",
      "details": "Intimation of Schedule of Meetings with Analyst/Institutional Investor(s)",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "12-Nov-2026",
      "details": "Intimation of Schedule of Meeting with Analyst/Institutional Investor(s)",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "02-Nov-2026",
      "details": "Intimation of Earnings Conference call transcript for Q2 FY2027",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has declared <strong>12%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Jun 19",
          "dt": "2019-06-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

16-Nov-2026 | Source : BSE

Intimation of Schedule of Meetings with Analyst/Institutional Investor(s)

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

12-Nov-2026 | Source : BSE

Intimation of Schedule of Meeting with Analyst/Institutional Investor(s)

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

02-Nov-2026 | Source : BSE

Intimation of Earnings Conference call transcript for Q2 FY2027

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Syngene International Ltd has declared 12% dividend, ex-date: 25 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Syngene International Ltd has announced 1:1 bonus issue, ex-date: 11 Jun 19

stock-summary
RIGHTS

No Rights history available